DRUG · Unmapped registry intervention
Endostatin
Find medicine records ·
Find other trials using this name
Clinical trial
Curative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung Cancer
NCT01218594
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedCurative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung Cancer
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
EndostatinDRUG
Sponsors & collaborators
Sun Yat-sen Universitylead sponsor
Fujian Province Tumor Hospitalcollaborator
Zhejiang Cancer Hospitalcollaborator
The 458 Hospital of Chinese PLAcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01218594 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.